Pathways linking early life stress, metabolic syndrome, and the inflammatory marker fibrinogen in depressed inpatients

Psychiatria Danubina

Volumn 24, Issue 1, 2012, Pages 57-65

  Zeugmann, Sara ^a   Quante, Arnim ^a   Popova Zeugmann, Louchka ^b   Kössler, Wolfgang ^b   Heuser, Isabella ^a   Anghelescu, Ion ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Depression; Early life stress; Fibrinogen; Inflammatory; Metabolic syndrome

Indexed keywords

BIOLOGICAL MARKER; FIBRINOGEN;

ADULT; ARTICLE; DEPRESSION; DISEASE SEVERITY; EPIGENETICS; FEMALE; HOSPITAL PATIENT; HUMAN; IMMUNOSTIMULATION; INFLAMMATION; LIFE STRESS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; METABOLIC SYNDROME X;

ADULT; AGED; CHILD; CHILD ABUSE; DEPRESSIVE DISORDER, MAJOR; ENDOPHENOTYPES; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION MEDIATORS; LIFE CHANGE EVENTS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MODELS, STATISTICAL; RISK FACTORS;

EID: 84860794794     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Alvarez J, Pavao J, Baumrind N, Kimerling R: The relationship between child abuse and adult obesity among Californian women. Am J Prev Med 2007; 33:28-33.
2. Avitsur R, Hunzeker J, Sheridan JF: Role of early stress in the individual differences in host response to viral infection. Brain Behav Immun 2006; 20:339-348.
3. Bamber M: CBT for occupational stress in health professionals: Introducing a schema focused approach. Routledge, London, 2006.
4. Bamber M & McMahon R: Danger-early maladaptive schemas at work!: The role of early maladaptive schemas in career choice and the development of occupational stress in health workers. Clin Psychol Psychother 2008; 15:96-112.
5. Bentler PM: Comparative fit indexes in structural models. Psychol Bull 1990; 107:238-246.
6. Bentler P & Bonett DG: Significance Tests and Goodness of Fit in the Analysis of Covariance-Structures. Psychological Bulletin 1980; 88:588-606.
7. Bernstein DP, Fink L, Handelsman L, Foote J, Lovejoy M, Wenzel K, Sapareto E, Ruggiero J: Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am J Psychiatry 1994; 151:1132-1136.
8. Best LG, North KE, Tracy RP, Lee ET, Howard BV, Palmieri V, Maccluer JW: Genetic determination of acute phase reactant levels: the strong heart study. Hum Hered 2004; 58:112-116.
9. Browne MW & Cudeck R: Alternative ways of assessing model fit. In Bollen KA & Long JS (eds.): Testing structural equation models, Sage Publications, 1993.
10. Chrousos GP: Organization and integration of the endocrine system. In Sperling M (ed): Pediatric Endocrinology, 1-14, Saunders, 1996.
11. Chrousos GP: The role of stress and the hypothalamicpituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int J Obes Relat Metab Disord 2000; 24 Suppl 2:S50-S55.
12. D'Argenio A, Mazzi C, Pecchioli L, Di Lorenzo G, Siracusano A, Troisi A: Early trauma and adult obesity: is psychological dysfunction the mediating mechanism? Physiol Behav 2009; 98:543-546.
13. Danese A, Moffitt TE, Harrington H, Milne BJ, Polanczyk G, Pariante CM, Poulton R, Caspi A: Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers. Arch Pediatr Adolesc Med 2009; 163:1135-1143.
14. Danese A, Moffitt TE, Pariante CM, Ambler A, Poulton R, Caspi A: Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatry 2008; 65:409-415.
15. Danese A, Pariante CM, Caspi A, Taylor A, Poulton R: Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci U.S.A 2007; 104:1319-1324.
16. Davies MJ: The contribution of thrombosis to the clinical expression of coronary atherosclerosis. Thromb Res 1996; 82:1-32.
17. Goldbacher EM, Bromberger J, Matthews KA: Lifetime history of major depression predicts the development of the metabolic syndrome in middle-aged women. Psychosom Med 2009; 71:266-272.
18. Gouin JP, Glaser R, Loving TJ, Malarkey WB, Stowell J, Houts C, Kiecolt-Glaser JK: Attachment avoidance predicts inflammatory responses to marital conflict. Brain Behav Immun 2009; 23:898-904.
19. Grilo CM, Masheb RM, Brody M, Toth C, Burke- Martindale CH, Rothschild BS: Childhood maltreatment in extremely obese male and female bariatric surgery candidates. Obes Res 2005; 13:123-130.
20. Haack M, Hinze-Selch D, Fenzel T, Kraus T, Kühn M, Schuld A, Pollmächer T: Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res 1999; 33:407-418.
21. Hamilton M: Standardised assessment and recording of depressive symptoms. Psychiatr Neurol Neurochir 1969; 72:201-205.
22. Harrison-Woolrych M & Ashton J: Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand. Drug Saf 2011; 763-772.
23. Hayduk L, Cummings G, Boadu K, Pazderka-Robinson H, Boulianne S: Testing! Testing! One, two, three - testing the theory in structural equation models! Personality and Individual Differences 2007; 42: 841-850.
24. Himmerich H, Fulda S, Linseisen J, Seiler H, Wolfram G, Himmerich S, Gedrich K, Kloiber S, Lucae S, Ising M, Uhr M, Holsboer F, Pollmächer T.: Depression, comorbidities and the TNF-α system. Eur Psychiatry 2008; 23:421-429.
25. Hu LT & Bentler PM: Evaluating model fit. In Hoyle RH (ed.): Structural Equation Modeling: Concepts, issues, and applications, 76-99, Sage, 1995.
26. Hu LT & Bentler PM: Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling 1999; 6:1-55.
27. Kannel WB, D'Agostino RB, Belanger AJ, Sibershatz H, Tofler GT: Long-term influence of fibrinogen on initial and recurrent cardiovascular events in men and women. Am J Cardiol 1996; 78:90-92.
28. Kim YK, Na KS, Shin KH, Jung HY, Choi SH, Kim JB: Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:1044-1053.
29. Koenig W: Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 2003; 89:601-609.
30. Kraus T, Haack M, Schuld A, Hinze-Selch D, Koethe D, Pollmächer T: Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine and venlafaxine. Pharmacopsychiatry 2002; 35:220-225.
31. Kudielka BM, Bellingrath S, von Kanel R: Circulating fibrinogen but not D-dimer level is associated with vital exhaustion in school teachers. Stress 2008; 11:250-258.
32. Laudenslager M, Capitanio JP, Reite M: Possible effects of early separation experiences on subsequent immune function in adult macaque monkeys. Am J Psychiatry 1985; 142:862-864.
33. Laudenslager ML, Reite M, Harbeck RJ: Suppressed immune response in infant monkeys associated with maternal separation. Behav Neural Biol 1982; 36:40-48.
34. 1a receptor in patients with major depression disorder. J Affect Disord 2010; 124:68-75.
35. Maes M: Major depression and activation of the inflammatory response system. Adv Exp Med Biol 1999; 461:25-46.
36. Mann DL: Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 2002; 91:988-998.
37. Pace TW, Mletzko TC, Alagbe O, Musselman DL, Nemeroff CB, Miller AH, Heim CM: Increased stress-nduced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry 2006; 163:1630-1633. (Pubitemid 44465765)
38. Pankow JS, Folsom AR, Province MA, Rao DC, Williams RR, Eckfeldt J, Sellers TA: Segregation analysis of plasminogen activator inhibitor-1 and fibrinogen levels in the NHLBI family heart study. Arterioscler Thromb Vasc Biol 1998; 18:1559-1567. (Pubitemid 28465407)
39. Piletz JE, Halaris A, Igbal O, Hoppenstaedt D, Fareed J, Zhu H, Sinacore J, Devane CL.: Pro-inflammatory biomarkers in depression: Treatment with venlafaxine. World J Biol Psychiatry 2009; 10:313-323.
40. Pulkki-Raback L, Elovainio M, Kivimaki M, Mattsson N, Raitakari OT, Puttonen S, Marniemi J, Viikari JS, Keltikangas-Jarvinen L: Depressive symptoms and the metabolic syndrome in childhood and adulthood: a prospective cohort study. Health Psychol 2009; 28:108-116.
41. Raikkonen K, Matthews KA, Kuller LH: The relationship between psychological risk attributes and the metabolic syndrome in healthy women: antecedent or consequence? Metabolism 2002; 51:1573-1577. (Pubitemid 36018831)
42. Raikkonen K, Matthews KA, Kuller LH: Depressive symptoms and stressful life events predict metabolic syndrome among middle-aged women: a comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions. Diabetes Care 2007; 30:872-877. (Pubitemid 46556580)
43. Ridker PM: The JUPITER trial: results, controversies, and implications for prevention. Circ Cardiovasc Qual Outcomes 2009; 2:279-285.
44. Rogowski O, Shapira I, Bassat OK, Chundadze T, Finn T, Berliner S, Steinvil A: Waist circumference as the predominant contributor to the micro-inflammatory response in the metabolic syndrome: a cross sectional study. J Inflamm (Lond) 2010; 7:35.
45. Russek LG & Schwartz GE: Feelings of parental caring predict health status in midlife: a 35-year follow-up of the Harvard Mastery of Stress Study. J Behav Med 1997; 20:1-13. (Pubitemid 27088123)
46. Schiepers OJ, Wichers MC, Maes M: Cytokines and major depression. Progr Neuropsychopharmacol Biol Psychiatry 2005; 29:201-217. (Pubitemid 40202906)
47. Sperner-Unterweger B: Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications. Drugs 2005; 65:1493-1520.
48. Sutherland JP, McKinley B, Eckel RH: The metabolic syndrome and inflammation. Metab Syndr Relat Disord 2004; 2:82-104. (Pubitemid 39545406)
49. Teran-Garcia M & Bouchard C: Genetics of the metabolic syndrome. Appl Physiol Nutr Metab 2007; 32:89-114.
50. Thomas C, Hypponen E, Power C: Obesity and type 2 diabetes risk in midadult life: the role of childhood adversity. Pediatrics 2008; 121:e1240-e1249.
51. Toker S, Shirom A, Shapira I, Berliner S, Melamed S: The association between burnout, depression, anxiety, and inflammation biomarkers: C-reactive protein and fibrinogen in men and women. J Occup Health Psychol 2005; 10:344-362. (Pubitemid 41636234)
52. Tracy RP: Thrombin, inflammation, and cardiovascular disease: an epidemiologic perspective. Chest 2003; 124:49S-57S.
53. Vaccarino V, McClure C, Johnson BD, Sheps DS, Bittner V, Rutledge T, Shaw LJ, Sopko G, Olson MB, Krantz DS, Parashar S, Marroquin OC, Merz CN: Depression, the metabolic syndrome and cardiovascular risk. Psychosom Med 2008; 70:40-48.
54. Vanhala M, Jokelainen J, Keinanen-Kiukaanniemi S, Kumpusalo E, Koponen H: Depressive symptoms predispose females to metabolic syndrome: a 7-year follow-up study. Acta Psychiatr Scand 2009; 119:137-142.
55. Vanitallie TB: Stress: a risk factor for serious illness. Metabolism 2002; 51:40-45.
56. Viinamaki H, Heiskanen T, Lehto SM, Niskanen L, Koivumaa-Honkanen H, Tolmunen T, Honkalampi K, Saharinen T, Haatainen K, Hintikka J: Association of depressive symptoms and metabolic syndrome in men. Acta Psychiatr Scand 2009; 120:23-29.
57. Warner J, Pitts N, Crawford M, Serfaty M, Prabhakaran P, Amin R: Sexual activity among patients in psychiatric hospital wards. J R Soc Med 2004; 97: 477-479. (Pubitemid 39424604)
58. Wiersma JE, Hovens, JG, van Oppen P, Giltay EJ, van Schaik, DJ, Beekman AT, Penninx, BW: The importance of childhood trauma and childhood life events for chronicity of depression and adults. J Clin Psychiatry 2009; 70:983-989.
59. Wildman RP, Kaplan R, Manson JE, Rajkovic A, Connelly SA, Mackey RH, Tinker LF, Curb JD, Eaton CB, Wassertheil-Smoller S: Body Size Phenotypes and Inflammation in the Women's Health Initiative Observational Study. Obesity (Silver Spring) 2011.
60. Wulff H: Childhood trauma questionnaire. University of Lübeck: Dissertation 2007.
61. Yan RT, Fernandes V, Yan AT, Cushman M, Redheuil A, Tracy R, Vogel-Claussen J, Bahrami H, Nasir K, Bluemke DA, Lima JA: Fibrinogen and left ventricular myocardial systolic function: The Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J 2010; 160:479-486.
62. Young JE, Klosko JS, Weishaar ME: Schema Therapy: A Practitioner's Guide. The Guilford Press, New York, 2006.
63. Zeugmann S, Quante A, Buehrsch N, Bajbouj M, Heuser I, Anghelescu I: Childhood maltreatment and adult proinflammatory status in patients with major depression. (Submitted).
64. Zeugmann S, Quante A, Heuser I, Schwarzer R, Anghelescu I: Inflammatory biomarkers in 70 depressed inpatients with and without the metabolic syndrome. J Clin Psychiatry 2010; 71:1007-1016.